Literature DB >> 6308335

[Disorders of hormone metabolism in chronic uremia].

M Weissel, H K Stummvoll.   

Abstract

Uremia is accompanied by a variety of "true" and "laboratory" endocrine disorders, due in part to impaired degradation of hormones because of failing kidney function and in part to the interference of the uremic environment with extrarenal degradation or synthesis and secretion of certain hormones. "True" endocrine disorders, like hyperparathyroidism or hypogonadism, that are associated with renal insufficiency are in contrast with "laboratory" endocrine disorders in uremia, where pathological serum hormone levels lack clearcut clinical evidence for dysfunction of the respective endocrine organ (e.g. thyroid gland). This lack of a direct cause and effect relationship in uremia may be due to the fact that immunoassayable hormone levels may include cross reacting components without biological activity in uremia and to the fact that the uremic environment may alter hormonal effects on target organs. This review tries to give a survey of the big amount of available clinical and laboratory data for uremia induced changes in the following hormones: growth hormone and somatomedins, prolactin, cortisol and adrenocorticotrope hormone, the gonadal and thyroid function as well as parathyroid hormone action. The knowledge of these uremia-induced changes should facilitate the clinician the diagnosis of an additional primary endocrine ailment in a uremic patient and should, on the other hand, spare these patients unnecessary treatment for a suspected endocrine disorder.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308335     DOI: 10.1007/bf01488714

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  71 in total

Review 1.  The Cushing syndromes: changing views of diagnosis and treatment.

Authors:  E M Gold
Journal:  Ann Intern Med       Date:  1979-05       Impact factor: 25.391

2.  Abnormalities in the regulation of prolactin in patients with chronic renal failure.

Authors:  G Ramirez; W M O'Neill; H A Bloomer; W Jubiz
Journal:  J Clin Endocrinol Metab       Date:  1977-10       Impact factor: 5.958

Review 3.  Genesis of hyperparathyroidism.

Authors:  E Reiss; J M Canterbury
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

4.  Serum gonadotropin and testosterone levels in uremic males undergoing intermittent dialysis.

Authors:  A Guevara; D Vidt; M C Hallberg; E M Zorn; C Pohlman; R G Wieland
Journal:  Metabolism       Date:  1969-12       Impact factor: 8.694

5.  Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin.

Authors:  F Gómez; R de la Cueva; J P Wauters; T Lemarchand-Béraud
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

6.  Exophthalmus in chronic renal insufficiency.

Authors:  P Schmidt; N Stobaeus; G Prame; F Schittek
Journal:  Scand J Urol Nephrol       Date:  1971

7.  Sexual function and hormonal abnormalities in uremic men on chronic dialysis and after renal transplantation.

Authors:  R T Chopp; R Mendez
Journal:  Fertil Steril       Date:  1978-06       Impact factor: 7.329

8.  Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis.

Authors:  G Ramirez; C Gomez-Sanchez; W A Meikle; W Jubiz
Journal:  Arch Intern Med       Date:  1982-08

9.  Hyperprolactinaemia in renal disease.

Authors:  E A Cowden; W A Ratcliffe; J G Ratcliffe; J W Dobbie; A C Kennedy
Journal:  Clin Endocrinol (Oxf)       Date:  1978-09       Impact factor: 3.478

10.  Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism.

Authors:  V S Lim; C Henriquez; H Seo; S Refetoff; E Martino
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.